Breast Cancer Clinical Trials

Breast Cancer Resources

This information is explained in much more detail on our sister website: AboutBreastHealth.com.

Breast Cancer Resources

This information is explained in much more detail on our sister website: AboutBreastHealth.com.

07.0072 - A Randomized Phase III Trial of Neoadjuvant Therapy in Patients with Palpable and Operable Breast Cancer Evaluating the Effect on Pathologic Complete Response (pCR) of Adding Capecitabine or Gemcitabine to Docetaxel when Administered Before AC with or without Bevacizumab and Correlative Science Studies Attempting to Identify Predictors of High Likelihood for pCR with Each of the Regimens learn more
05.0511 - Suppression of Ovarian Function Trial (SOFT) - A Phase III Trial Evaluating the Role of Ovarian Function Suppression and the Role of Exemestane Adjuvant Therapies for Premenopausal Women with Endocrine Responsive Breast Cancer Tamoxifen versus Ovarian Function Suppression + Tamoxifen Versus Ovarian Function Suppression + Exemestane learn more
06.0362 - Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning Individualized Options for Treatment the TAILORx Trial learn more
08.0532 - A Randomized Phase III Trial Comparing a Neoadjuvant Regimen of FED-75 Followed By Paclitaxel Plus Trastuzumab with a Neoadjuvant regimen of Paclitaxel Plus Trastuzumab Followed by FEC-75 Plus Trastuzumab in Patients with HER-2 Positive Operable Breast Cancer learn more
09.0282 - Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer learn more
09.0131 - ALTTO – Adjuvant Lapatinib and/or Trastuzumab Treatment Optimisation Study; A Randomised, Multi-centre, Open-label, Phase III Study of Adjuvant Lapatinib, Trastuzumab, Their Sequence and Their Combination in Patients with HER2/ErbB2 Positive Primary Breast Cancer learn more
09.0287 - A randomized Phase III study of Conventional Whole Breast Irradiation (WBI) versus Partial Breast Irradiation (PBI) for Women with stage 0, I, or II Breast Cancer learn more
09.0484 - A Randomized Double-Blind, Placebo-Controlled Study of Everolimus in Combination with Exemestane in the Treatment of Postmenopausal Women with Estrogen Receptor Positive, Locally Advanced or Metastatic Breast Cancer who are refractory to Letrozole or Anastrozole. learn more
09.0484 - A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide followed by Paclitaxel with Bevacizumab or Placebo in Patients with Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer learn more
06.0585 - A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women with Hormonal Receptor Positive Breast Cancer learn more
07.0182 - Patient Satisfaction and Quality of Life: University Surgical Associates Breast Clinic learn more
08.0452 - Procedures and Outcomes in Breast Cancer Detection, Treatment and Diagnosis: A Data Collection Study learn more